Symic Bio Alternatives & Competitors
12 companies similar to Symic Bio — A new category of therapeutics based on extracellular matrix biology
Companies similar to Symic Bio
Emalex Biosciences
Improving people's lives impacted by central nervous system disorders through meaningful s...
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
Ansun Biopharma, Inc.
Discovering solutions for the world
Neurolixis
New treatments for central nervous system disorders
Rival Readout
Competing with Symic Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Yaqrit
The Liver Disease Company
Alivio Therapeutics
Pioneering precision immunomodulation to tackle chronic and acute inflammatory disorders a...
Connect Biopharma
Global Clinical Stage Company Connecting Patients with Innovation for Life
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
TARIS
Innovative therapies for challenging bladder conditions, with a tailored, extended-release...
NorthSea Therapeutics
Clinical-stage biopharmaceutical company focused on the development of structurally engine...
AAVantgarde
Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
About Symic Bio
Symic Bio, founded in 2012, is a pioneering company in the Biotechnology and Health Care industries, headquartered in the United States. The company has positioned itself as a leader in creating a new category of therapeutics based on extracellular matrix (ECM) biology, an approach that holds significant potential for...
Therapeutic Drug Development, Biomedical Research, Clinical Trial Management
Healthcare Providers, Pharmaceutical Companies, Research Institutions, Patients
Biomedical Technology, Therapeutics, Matrix Regulator, Fibrosis Treatment, Oncology Treatment, Central Nervous System Disorders, Inflammatory Response Modulation, Medical Research, Biotech Startup, Innovative Therapies, Matrix Degradation, Disease Treatment, Clinical Applications, Biopharmaceuticals
B2B
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Symic Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Symic Bio on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 6 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.